AI assistant
Dowlais Group PLC — Director's Dealing 2023
Oct 26, 2023
6265_dirs_2023-10-26_0ead61f5-2016-402b-8ec8-de92841082e0.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 4383R
Dowlais Group PLC
26 October 2023
26 October 2023
Dowlais Group plc
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
This notification has been made in accordance with the requirements of The UK Market Abuse Regulation.
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| (a) | Name | Celia Frances Baxter | |
| 2. | Reason for the notification | ||
| (a) | Position / status | Non-Executive Director (Person Discharging Managerial Responsibilities) | |
| (b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction | ||
| (a) | Name | Dowlais Group plc | |
| (b) | LEI | 213800XM8WOFLY6VPC92 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| (a) | Description of the financial instrument Identification code |
Dowlais Group plc ordinary shares of 1 pence each GB00BMWRZ071 |
|
| (b) | Nature of the transaction | Purchase of ordinary Shares in Dowlais Group plc | |
| (c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| £0.888286 | 22,836 | ||
| £0.877196 | 12,251 | ||
| (d) | Aggregated information Aggregated volume Price |
35,087 shares £0.884 per share |
|
| (e) | Date of the transaction | 26 October 2023 | |
| (f) | Place of the transaction | London Stock Exchange (XLON) |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFEWFFMEDSELS